Evidence map›Paper›PMID 25889716›Full record

ArticleBMC veterinary research2015

Characterization of a caprine model for the subclinical initial phase of Mycobacterium avium subsp. paratuberculosis infection.

Heike Köhler, Anneka Soschinka, Michaela Meyer, Angela Kather, Petra Reinhold, Elisabeth Liebler-Tenorio

Open access · goldAbstract read
In one paragraph

Article in BMC veterinary research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Prevalence and Genotyping ofVeterinary sciences · 2025
    Article
  5. Interferon-gamma producing CD4Veterinary research · 2024
    Article
  6. Antibiotics (Basel, Switzerland) · 2024
    Article
  7. Molecular Diversity ofAnimals : an open access journal from MDPI · 2023
    Article
  8. Animals : an open access journal from MDPI · 2023
    Article
  9. Animals : an open access journal from MDPI · 2023
    Article
  10. Safety and Immunogenicity of RecombinantInternational journal of molecular sciences · 2023
    Article
  11. Article
  12. Article
  13. Interferon-γ Response ofFrontiers in veterinary science · 2021
    Article
  14. Article
  15. Review
  16. Detection ofFrontiers in veterinary science · 2021
    Article
  17. A Bovine EntericFrontiers in immunology · 2020
    Article
  18. Article
  19. Review
  20. Morphological and Molecular Characterization of a NewFrontiers in veterinary science · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Heike KöhlerInstitute of Molecular Pathogenesis, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Jena, Germany. heike.koehler@fli.bund.de.
Anneka SoschinkaInstitute of Molecular Pathogenesis, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Jena, Germany. asoschinka@web.de.
Michaela MeyerInstitute of Molecular Pathogenesis, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Jena, Germany. meneguana@gmx.de.
Angela KatherInstitute of Molecular Pathogenesis, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Jena, Germany. angela.kather@web.de.
Petra ReinholdInstitute of Molecular Pathogenesis, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Jena, Germany. petra.reinhold@fli.bund.de.
Elisabeth Liebler-TenorioInstitute of Molecular Pathogenesis, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Jena, Germany. elisabeth.liebler-tenorio@fli.bund.de.
Friedrich-Loeffler-Institut · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundParatuberculosis caused by Mycobacterium avium subsp. paratuberculosis (MAP) is difficult to control due to a long phase of clinically non-apparent (latent) infection for which sensitive diagnostics are lacking. A defined animal model for this phase of the infection can help to investigate host-MAP interactions in apparently healthy animals and identify surrogate markers for disease progress and might also serve as challenge model for vaccines. To establish such a model in goats, different age at inoculation and doses of oral inoculum of MAP were compared. Clinical signs, faecal shedding as well as MAP-specific antibody, IFN-γ and IL-10 responses were used for in vivo monitoring. At necropsy, about one year after inoculation (pi), pathomorphological findings and bacterial organ burden (BOB) were scored.

resultsMAP infection manifested in 26/27 inoculated animals irrespective of age at inoculation and dose. Clinical signs developed in three goats. Faecal shedding, IFN-γ and antibody responses emerged 6, 10-14 and 14 wpi, respectively, and continued with large inter-individual variation. One year pi, lesions were detected in 26 and MAP was cultured from tissues of 23 goats. Positive animals subdivided in those with high and low overall BOB. Intestinal findings resembled paucibacillary lesions in 23 and multibacillary in 4 goats. Caseous and calcified granulomas predominated in intestinal LNN. BOB and lesion score corresponded well in intestinal mucosa and oGALT but not in intestinal LNN.

conclusionsA defined experimental infection model for the clinically non-apparent phase of paratuberculosis was established in goats as suitable basis for future studies.

Indexed as

Mycobacterium avium subsp. paratuberculosisAnimalsAntibody FormationAsymptomatic InfectionsBacterial SheddingDisease ProgressionGoat DiseasesGoatsInterferon-gammaInterleukin-10Lymph NodesMaleParatuberculosisPeyer's PatchesInterferon-gammaInterleukin-10

Identifiers

PMID25889716
PMCPMC4404677
OpenAlexW2040078189

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.